Abstract |
The anti- cancer drug aclarubicin (2.0 mg/kg body weight) was injected into the left popliteal lymph node (the primary draining node of the foot-pad region) or into the tail vein, 8 days after a subcutaneous inoculation of 5 x 10(5) P388 leukemia cells/mouse in the left hind paw foot-pad of mouse (donor). During this time, metastases were established in the lower para-aortic nodes (the secondary draining nodes of this region). On day 10, the lower para-aortic nodes taken from each donor were transferred intraperitoneally to a normal mouse (recipient). From the recipients' survival time, the viable P388 leukemia cell number in the para-aortic nodes per donor mouse was estimated with a calibration line. The recipients' survival curve in the intralymphatic chemotherapy group was statistically significantly better than that in the intravenous chemotherapy group.
|
Authors | A Hagiwara, T Takahashi, K Sawai, K Seiki, M Ito, C Sakakura, S Shobayashi |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 2
Issue 6
Pg. 549-53
(Dec 1991)
ISSN: 0959-4973 [Print] England |
PMID | 1806032
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Aclarubicin
|
Topics |
- Aclarubicin
(pharmacology)
- Animals
- Antineoplastic Agents
(pharmacology)
- Calibration
- Disease Models, Animal
- Female
- Injections, Intralymphatic
- Leukemia P388
(drug therapy, pathology)
- Lymphatic Metastasis
(pathology)
- Mice
- Mice, Inbred Strains
- Neoplasm Transplantation
- Tumor Cells, Cultured
(drug effects)
|